Boštíková V., Smetana J., Boštík P., Chlíbek R., Špliňo M.: Polio News

Czech version

Authors: V. Boštíková ¹; J. Smetana ¹; P. Boštík ²; R. Chlíbek ¹; M. Špliňo ¹
Authors‘ workplace: Katedra epidemiologie, Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové ¹; Centrum pokročilých studií, Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové ²
Published in: Epidemiol. Mikrobiol. Imunol. 60, 2011, č. 1, s. 38-40

Overview

Although the Word Health Organization (WHO) launched the global polio eradication initiative 22 years ago, reports of new cases of this serious disease from various parts of the world are far from being uncommon. Former Czechoslovakia became the first country in the world to achieve polio eradication at the nationwide level. Since summer 1960, no case of non-imported paralytic poliomyelitis has been reported since 1961, Czechoslovakia has been the first country in the world to control permanently the spread of wild poliovirus strains.

Keywords:
polio – wild virus – vaccine.

Sources

1. Heymann, D. L., Sutter, R. W., Aylward, R. B. Polio eradication: interrupting transmission, towards a polio--free world. Future Virology, 2006, 1, p. 181–188.

2. Chlíbek, R., Smetana, J., Kosina, P. Lexikon očkovacích látek dostupných v ČR. Olomouc 2010.

3. Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., Pallansch, M. A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann. Rev. Microbiol., 2005, 59, p. 587–635.

4. Liu, X., Levin, A., Makinen, M., Day, J. OPV vs IPV: past and future choice of vaccine in the Global Polio Eradication Program. Partners for health Reform Document. Abt. Associates, Inc., 2003.

5. Minor, P. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. Ann. Rev. Microbiol., 2009, 27 (20), p. 2649–2652.

6. Slonin, D., Švandová, E. Poliomyelitida v České republice 1919–1999. Medon: Praha, 2001.

7. WHO Global Alert and response (GAR) Disease Outbreak News.

8. WHO. Guidelines for environmental surveillance of poliovirus circulation. WHO, Geneva, 2003.

9. WHO. Polio laboratory manual. WHO, Geneva, 2004.

Labels

Hygiene and epidemiology Medical virology Clinical microbiology

Vlčková J., Rupeš V., Chmela J., Kenša M., Mazánek L.: In vitro Efficacy of Three Novel Delousing Formulations against the Head Louse (Pediculus capitis L.)

Bazovská S., Ďurovská J., Pancák J., Záborská M., Derdáková. M.: Lyme Borreliosis and Demyelinating Disease of the Central Nervous System

Hrabák J., Žemličková H., Bergerová T., Urbášková P.: Interpretation of the Susceptibility Test Results in Enterobacteria Producing 3rd- and 4th-Generation Cephalosporin- or Carbapenem-Hydrolyzing β-Lactamases

Urbášková P., Žemličková H., PSMR: Antibiotic Resistance of Streptococcus pneumoniae and Streptococcus pyogenes in 1996–2009

Mravčík V., Nechanská B., Šťastná L.: Residential Care for Substance Users and Addicts in the Czech Republic according to the Health Statistics since 1959

Kissová R., Maďarová L., Klement C.: Laboratory Diagnosis of Pandemic Influenza at the Department of Medical Microbiology of the Regional Authority of Public Health Based in Banská Bystrica in the Season 2009–2010

Article was published in

Epidemiology, Microbiology, Immunology

2011 Issue 1